Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/25 16:35 | 7/1/25 | ATHA | Health | BioPrd | Biological Products, (No Diag | Church Kevin | WA | O | Chief Sc | 3 | S.d | -9 | 0.4454 | 0 | -20 | 169 | D | |||||||||||||||
7/2/25 16:34 | 7/1/25 | ATHA | Health | BioPrd | Biological Products, (No Diag | Litton Mark James | WA | DO | P,CEO | 3 | S.d | -24 | 0.4403 | 0 | -55 | 345 | D | |||||||||||||||
7/2/25 16:33 | 7/1/25 | ATHA | Health | BioPrd | Biological Products, (No Diag | San Martin Javier | WA | O | CHIEF ME | 2 | S.d | -9 | 0.4276 | 0 | -22 | 72 | D | |||||||||||||||
7/2/25 16:33 | 7/1/25 | ATHA | Health | BioPrd | Biological Products, (No Diag | Worthington Mark | WA | O | GC,CCO | 3 | S.d | -9 | 0.4454 | 0 | -20 | 112 | D | |||||||||||||||
7/2/25 16:32 | 7/1/25 | ATHA | Health | BioPrd | Biological Products, (No Diag | Renninger Robert | WA | O | SVP,Fina | 2 | S.d | -2 | 0.4273 | 0 | -6 | 109 | D | |||||||||||||||
9/5/24 19:51 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | CFO,CHIE | 1 | S | -1 | 0.5660 | 0 | -1 | 98 | D | |||||||||||||||
9/5/24 19:50 | 9/5/24 | ATHA | Health | BioPrd | Biological Products, (No Diag | Lenington Rachel | WA | O | COO,CDO | 1 | S | -1 | 0.5659 | 0 | -3 | 21 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |